Noile-Immune Biotech Inc
4893
Company Profile
Business description
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.
Contact
2-12-10 Shiba-Daimon
Minato-ku
Tokyo105-0012
JPNT: +81 358437819
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
33
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,234.60 | 59.50 | 0.73% |
| CAC 40 | 7,536.26 | 33.48 | 0.45% |
| DAX 40 | 22,242.45 | 177.94 | 0.81% |
| Dow JONES (US) | 40,113.50 | 20.10 | 0.05% |
| FTSE 100 | 8,415.25 | 7.81 | 0.09% |
| HKSE | 21,997.08 | 16.34 | 0.07% |
| NASDAQ | 17,382.94 | 216.90 | 1.26% |
| Nikkei 225 | 35,843.62 | 137.88 | 0.39% |
| NZX 50 Index | 12,097.69 | 79.85 | 0.66% |
| S&P 500 | 5,525.21 | 40.44 | 0.74% |
| S&P/ASX 200 | 8,028.90 | 60.70 | 0.76% |
| SSE Composite Index | 3,294.02 | 1.04 | -0.03% |